ZA756550B - Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms - Google Patents

Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms

Info

Publication number
ZA756550B
ZA756550B ZA00756550A ZA756550A ZA756550B ZA 756550 B ZA756550 B ZA 756550B ZA 00756550 A ZA00756550 A ZA 00756550A ZA 756550 A ZA756550 A ZA 756550A ZA 756550 B ZA756550 B ZA 756550B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
antipsychotic activity
extrapyramidal symptoms
producing
producing antipsychotic
Prior art date
Application number
ZA00756550A
Other languages
English (en)
Inventor
C Zirkle
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Priority to US05/655,587 priority Critical patent/US4086350A/en
Publication of ZA756550B publication Critical patent/ZA756550B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA00756550A 1974-11-06 1975-10-16 Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms ZA756550B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/655,587 US4086350A (en) 1974-11-06 1976-02-05 Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52121674A 1974-11-06 1974-11-06

Publications (1)

Publication Number Publication Date
ZA756550B true ZA756550B (en) 1976-09-29

Family

ID=24075868

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00756550A ZA756550B (en) 1974-11-06 1975-10-16 Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms

Country Status (17)

Country Link
JP (1) JPS5826754B2 (fr)
AU (1) AU498298B2 (fr)
BE (1) BE835224A (fr)
CA (1) CA1055945A (fr)
CH (1) CH624403A5 (fr)
DE (1) DE2549841A1 (fr)
DK (1) DK139429B (fr)
ES (1) ES442357A1 (fr)
FR (1) FR2290202A1 (fr)
HU (1) HU174639B (fr)
IE (1) IE42137B1 (fr)
IL (1) IL48400A (fr)
LU (1) LU73714A1 (fr)
NL (1) NL7512974A (fr)
NZ (1) NZ179139A (fr)
PH (1) PH12158A (fr)
ZA (1) ZA756550B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357251A1 (fr) * 1976-07-09 1978-02-03 Merck & Co Inc 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4089961A (en) * 1976-11-08 1978-05-16 Smithkline Corporation Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (fr) * 1988-11-30 1990-05-31 Masataka Syoji Derives de piperidine et hypotenseurs les contenant
EP1306376A1 (fr) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Dérives de 4-(thio- or selenoxanthene-9-ylidene)-piperidine ou acridine et leur application comme antagonistes selectives de 5-HT2B
US7060711B2 (en) 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EA015491B1 (ru) * 2003-06-27 2011-08-30 Янссен Фармацевтика Н.В. ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
KR20080027216A (ko) 2004-08-05 2008-03-26 얀센 파마슈티카 엔.브이. 트리사이클릭 δ-오피오이드 조절자
EP1836196A1 (fr) * 2004-12-22 2007-09-26 Janssen Pharmaceutica N.V. Modulateurs des recepteurs opioides delta tricycliques
CA2591963A1 (fr) 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Modulateurs des recepteurs opioides $g(d) tricycliques
KR20070087675A (ko) 2004-12-22 2007-08-28 얀센 파마슈티카 엔.브이. 트리사이클릭 δ-오피오이드 모듈레이터
AU2006203880A1 (en) 2005-01-06 2006-07-13 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
WO2006138528A2 (fr) 2005-06-16 2006-12-28 Janssen Pharmaceutica N.V Modulateurs d'opioides tricycliques
AU2007301145B2 (en) 2006-09-29 2012-12-13 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260070A (fr) * 1960-02-25
NL122808C (fr) * 1961-09-29
DE1670118A1 (de) * 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
JPS5018478A (fr) * 1973-05-17 1975-02-26

Also Published As

Publication number Publication date
DK495775A (fr) 1976-05-07
IE42137B1 (en) 1980-06-04
JPS5826754B2 (ja) 1983-06-04
DE2549841A1 (de) 1976-05-13
HU174639B (hu) 1980-02-28
FR2290202B1 (fr) 1980-05-23
IE42137L (en) 1976-05-06
DK139429C (fr) 1979-08-06
IL48400A0 (en) 1976-01-30
AU8624775A (en) 1977-05-05
DE2549841C2 (fr) 1988-07-07
AU498298B2 (en) 1979-03-01
IL48400A (en) 1979-01-31
ES442357A1 (es) 1977-04-01
NL7512974A (nl) 1976-05-10
JPS5170768A (fr) 1976-06-18
LU73714A1 (fr) 1976-06-11
NZ179139A (en) 1978-04-28
BE835224A (fr) 1976-05-04
PH12158A (en) 1978-11-10
DK139429B (da) 1979-02-19
CA1055945A (fr) 1979-06-05
CH624403A5 (en) 1981-07-31
FR2290202A1 (fr) 1976-06-04

Similar Documents

Publication Publication Date Title
ZA756550B (en) Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
JPS5257176A (en) Production of novel imidazolidine and pharmaceutical composition
IL50836A0 (en) Novel cyclopolypeptides their production and pharmaceutical compositions containing them
CS181182B2 (en) Vehiculum of medicament and method of its produce
IL46760A (en) 2-tetrahydrofurfuryl-6,7-benzomorphane derivatives,their production and pharmaceutical compositions containing them
IL47877A (en) Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
IL52858A0 (en) New derivatives of perhydro-aza-heterocycles their production and pharmaceutical compositions containing them
IL47735A (en) 8a-substituted-6-alkyl-ergoline i derivatives,their production and pharmaceutical compositions containing them
JPS527999A (en) Production of evrnamenine derivatives and pharmaceutical composition
HU174129B (hu) Sposob poluchenija farmacevticheskikh kompozicijj s antibioticheskojj aktivnoct'ju
HU172659B (hu) Sposob poluchenija proizvodnykh tiazolidina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
IL51426A0 (en) Novel derivatives of tetrahydroechinocandin b their production and pharmaceutical compositions containing them
IL47117A (en) Process for the isolation of gamma-l-glutamyl-taurine and pharmaceutical compositions containing
IL46809A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
IL48640A (en) 1-alkyl-2-(phenoxymethyl)-5-nitro-imidazoles and process for their manufacture
IL48054A (en) 14-deoxy-14-substituted vincanol derivatives their production and pharmaceutical compositions containing them
JPS525799A (en) Production of indroquinolidine derivative and pharmaceutical composition containing same
IL46556A0 (en) New benzofuran derivatives,their production and pharmaceutical compositions containing them
HU173952B (hu) Sposob poluchenija novykh beta-laktam antibiotikov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU170891B (hu) Sposob poluchenija diuretichnykh i antigipertenziv farmacevticheskikh kompozicijj
IL45587A0 (en) Production of protein
HK23581A (en) Piperidine derivatives and processes for their manufacture
IL50198A0 (en) New morphanthridine derivatives their production and pharmaceutical compositions containing them
PH12431A (en) 1-aryl-uracil,derivatives,pharmaceutical composition and method of use
JPS5231930A (en) Catalytically active composition and its production method